• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于单硬脂酸甘油酯的植入剂的释放动力学与机制:在模拟体内植入的凝胶中的释放评估

Kinetics and mechanism of release from glyceryl monostearate-based implants: evaluation of release in a gel simulating in vivo implantation.

作者信息

Allababidi S, Shah J C

机构信息

Department of Pharmaceutical Sciences, Medical University of South Carolina, Charleston, South Carolina 29425, USA.

出版信息

J Pharm Sci. 1998 Jun;87(6):738-44. doi: 10.1021/js9703986.

DOI:10.1021/js9703986
PMID:9607952
Abstract

The overall objective of the study was to design an implantable delivery system based on glyceryl monostearate (GMS) for the site-specific delivery of antibiotics for the prevention of surgical wound infection. To design the implant, a release method had to be developed that simulate the in vivo implantation conditions to be able to predict the release characteristics from the implants when they are actually used in vivo. Also, identifying the release kinetics and mechanism and evaluating the factors that influence the release of drugs from the GMS-based matrix were necessary to allow further design of implants that could yield a desired release rate. The release of cefazolin was monitored from GMS matrixes implanted into agar gel, simulating subcutaneous tissues with respect to viscosity and water content. The gel method resulted in observation of spatial and temporal concentration profiles in the immediate vicinity of the implants, indicating the benefits of local drug delivery; however, there was no significant difference between the cumulative release profiles by the gel method or the vial release method. The release of cefazolin from the GMS-based matrix with the vial method followed Higuchi's square root of time kinetics. The release rate was found to be directly proportional to cefazolin load (A) and the surface area (SA) of the matrix as expressed by the following equation: = 0.24ASA. On the basis of this equation, one can design a variety of GMS matrixes that would result in a desired release rate or release duration. This also indicated that cefazolin release followed the release kinetics of a freely soluble drug from an insoluble matrix and hence it is a diffusion-controlled process. The effect of drug solubility on the release kinetics was determined by comparing the release kinetics of the poorly water soluble ciprofloxacin (0.16 mg/mL) to that of the highly water soluble cefazolin (325 mg/mL). The release duration of ciprofloxacin (80 h) was longer than that of cefazolin (25 h) from identical GMS matrixes. Although ciprofloxacin release was initially controlled by the matrix, agitation accelerated disintegration of the matrix and release due to its poor solubility, and ciprofloxacin release appeared to be a dissolution-controlled process following zero-order release kinetics.

摘要

本研究的总体目标是设计一种基于单硬脂酸甘油酯(GMS)的可植入给药系统,用于抗生素的局部给药,以预防手术伤口感染。为了设计该植入物,必须开发一种能模拟体内植入条件的释放方法,以便能够预测植入物在实际体内使用时的释放特性。此外,确定释放动力学和机制,并评估影响基于GMS的基质中药物释放的因素,对于进一步设计能够产生所需释放速率的植入物是必要的。通过将头孢唑林从植入琼脂凝胶的GMS基质中释放出来进行监测,琼脂凝胶在粘度和含水量方面模拟皮下组织。凝胶法导致观察到植入物紧邻区域的空间和时间浓度分布,表明局部给药的益处;然而,凝胶法或小瓶释放法的累积释放曲线之间没有显著差异。用小瓶法从基于GMS的基质中释放头孢唑林遵循Higuchi的时间平方根动力学。发现释放速率与头孢唑林负载量(A)和基质的表面积(SA)成正比,由以下方程表示:= 0.24ASA。基于该方程,可以设计出各种能产生所需释放速率或释放持续时间的GMS基质。这也表明头孢唑林的释放遵循从不溶性基质中自由溶解药物的释放动力学,因此它是一个扩散控制过程。通过比较水溶性差的环丙沙星(0.16 mg/mL)和水溶性高的头孢唑林(325 mg/mL)的释放动力学,确定了药物溶解度对释放动力学的影响。从相同的GMS基质中,环丙沙星的释放持续时间(80小时)比头孢唑林(25小时)长。尽管环丙沙星的释放最初受基质控制,但由于其溶解度差,搅拌加速了基质的崩解和释放,并且环丙沙星的释放似乎是遵循零级释放动力学的溶解控制过程。

相似文献

1
Kinetics and mechanism of release from glyceryl monostearate-based implants: evaluation of release in a gel simulating in vivo implantation.基于单硬脂酸甘油酯的植入剂的释放动力学与机制:在模拟体内植入的凝胶中的释放评估
J Pharm Sci. 1998 Jun;87(6):738-44. doi: 10.1021/js9703986.
2
Efficacy and pharmacokinetics of site-specific cefazolin delivery using biodegradable implants in the prevention of post-operative wound infections.使用可生物降解植入物进行头孢唑林局部给药预防术后伤口感染的疗效和药代动力学
Pharm Res. 1998 Feb;15(2):325-33. doi: 10.1023/a:1011939323560.
3
Biodegradable polyanhydride devices of cefazolin sodium, bupivacaine, and taxol for local drug delivery: preparation, and kinetics and mechanism of in vitro release.用于局部给药的头孢唑林钠、布比卡因和紫杉醇的可生物降解聚酸酐装置:制备以及体外释放动力学和机制
J Control Release. 1998 Mar 2;52(1-2):179-89. doi: 10.1016/s0168-3659(97)00223-x.
4
Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique II. In vitro drug release studies and release mechanisms.采用新型冷冻造粒技术II制备的蜡基缓释骨架微丸。体外药物释放研究及释放机制。
Int J Pharm. 2008 Jul 9;359(1-2):167-73. doi: 10.1016/j.ijpharm.2008.04.001. Epub 2008 Apr 11.
5
Formulation and evaluation of controlled release antibiotic biodegradable implants for post operative site delivery.用于术后部位递送的控释抗生素可生物降解植入物的制剂和评价。
Acta Pharm. 2010 Mar;60(1):111-7. doi: 10.2478/v10007-010-0005-z.
6
Novel biopolymers as implant matrix for the delivery of ciprofloxacin: biocompatibility, degradation, and in vitro antibiotic release.新型生物聚合物作为环丙沙星递送的植入物基质:生物相容性、降解及体外抗生素释放
J Pharm Sci. 2007 Jan;96(1):132-44. doi: 10.1002/jps.20730.
7
The design of flexible ciprofloxacin-loaded PLGA implants using a reversed phase separation/coacervation method.采用相反相分离/共凝聚法设计载有环丙沙星的可弯曲 PLGA 植入物。
Eur J Pharm Biopharm. 2011 Feb;77(2):233-9. doi: 10.1016/j.ejpb.2010.11.014. Epub 2010 Dec 9.
8
A controlled antibiotic release system to prevent orthopedic-implant associated infections: An in vitro study.一种用于预防骨科植入物相关感染的可控抗生素释放系统:一项体外研究。
Eur J Pharm Biopharm. 2015 Oct;96:264-71. doi: 10.1016/j.ejpb.2015.08.007. Epub 2015 Aug 18.
9
Cubic phase gels as drug delivery systems.立方相凝胶作为药物递送系统。
Adv Drug Deliv Rev. 2001 Apr 25;47(2-3):229-50. doi: 10.1016/s0169-409x(01)00108-9.
10
Bone implants modified with cyclodextrin: study of drug release in bulk fluid and into agarose gel.用环糊精修饰的骨植入物:在散装流体和琼脂糖凝胶中的药物释放研究。
Int J Pharm. 2010 Nov 15;400(1-2):74-85. doi: 10.1016/j.ijpharm.2010.08.035. Epub 2010 Sep 8.

引用本文的文献

1
In vitro-in vivo correlation (IVIVC) development for long-acting injectable drug products based on poly(lactide-co-glycolide).基于聚(丙交酯-乙交酯)的长效注射用药物产品的体外-体内相关性(IVIVC)研究
J Control Release. 2025 Jan 10;377:186-196. doi: 10.1016/j.jconrel.2024.11.021. Epub 2024 Nov 19.
2
Recent Advances of Ocular Drug Delivery Systems: Prominence of Ocular Implants for Chronic Eye Diseases.眼部给药系统的最新进展:眼用植入物在慢性眼病治疗中的突出地位。
Pharmaceutics. 2023 Jun 15;15(6):1746. doi: 10.3390/pharmaceutics15061746.
3
In vitro dissolution testing models of ocular implants for posterior segment drug delivery.
用于后段药物递送的眼部植入物的体外溶解测试模型。
Drug Deliv Transl Res. 2022 Jun;12(6):1355-1375. doi: 10.1007/s13346-021-01043-z. Epub 2021 Aug 11.
4
Muscle Tissue as a Surrogate for In Vitro Drug Release Testing of Parenteral Depot Microspheres.肌肉组织作为注射用储库型微球体外药物释放试验的替代物。
AAPS PharmSciTech. 2021 Mar 29;22(3):119. doi: 10.1208/s12249-021-01965-4.
5
Mathematical Modeling of Release Kinetics from Supramolecular Drug Delivery Systems.超分子药物递送系统释放动力学的数学建模
Pharmaceutics. 2019 Mar 21;11(3):140. doi: 10.3390/pharmaceutics11030140.
6
Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies.用于塞来昔布经皮给药的液晶系统:体外药物释放和皮肤渗透研究
AAPS PharmSciTech. 2014 Dec;15(6):1468-75. doi: 10.1208/s12249-014-0171-2. Epub 2014 Jul 1.
7
Development of hydrophobized alginate hydrogels for the vessel-simulating flow-through cell and their usage for biorelevant drug-eluting stent testing.用于模拟血管流动的亲水化海藻酸盐水凝胶的开发及其在生物相关药物洗脱支架测试中的应用。
AAPS PharmSciTech. 2013 Sep;14(3):1209-18. doi: 10.1208/s12249-013-0011-9. Epub 2013 Aug 6.
8
Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin.甘油脂单油酸酯/泊洛沙姆 407 立方纳米粒作为口服给药系统:I. 体外评价及辛伐他汀的口服生物利用度的改善。
AAPS PharmSciTech. 2009;10(3):960-6. doi: 10.1208/s12249-009-9292-4. Epub 2009 Jul 28.
9
Towards more realistic in vitro release measurement techniques for biodegradable microparticles.迈向更具现实意义的可生物降解微粒体外释放测量技术
Pharm Res. 2009 Mar;26(3):691-9. doi: 10.1007/s11095-008-9747-4. Epub 2008 Oct 29.
10
In vitro and in vivo evaluations of biodegradable implants for hormone replacement therapy: effect of system design and PK-PD relationship.用于激素替代疗法的可生物降解植入物的体外和体内评估:系统设计的影响及药代动力学-药效学关系
AAPS PharmSciTech. 2001 Sep 21;2(3):E16. doi: 10.1208/pt020316.